IL17A and cancer: TRAF4 has been reported as a positive regulator for cell growth/proliferation pathways (AKT, ERK1/2, and ERK5) induced by EGF, TGF-β, and IL-17A signaling, contributing to the proliferation and migration of cancer cells (47, 59–61).